Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$216K Hold
14,017
﹤0.01% 574
2025
Q4
$253K Hold
14,017
﹤0.01% 540
2025
Q3
$226K Hold
14,017
﹤0.01% 561
2025
Q2
$153K Hold
14,017
﹤0.01% 570
2025
Q1
$175K Hold
14,017
﹤0.01% 541
2024
Q4
$278K Hold
14,017
﹤0.01% 481
2024
Q3
$115K Hold
14,017
﹤0.01% 560
2024
Q2
$95.5K Buy
+14,017
New +$95.8K ﹤0.01% 577
2024
Q1
Sell
-12,218
Closed -$26.9K 626
2023
Q4
$26.9K Hold
12,218
﹤0.01% 597
2023
Q3
$30.1K Hold
12,218
﹤0.01% 612
2023
Q2
$95.5K Hold
12,218
﹤0.01% 390
2023
Q1
$80.4K Hold
12,218
﹤0.01% 395
2022
Q4
$71.1K Hold
12,218
﹤0.01% 404
2022
Q3
$62K Hold
12,218
﹤0.01% 399
2022
Q2
$54K Hold
12,218
﹤0.01% 416
2022
Q1
$103K Hold
12,218
﹤0.01% 404
2021
Q4
$117K Hold
12,218
﹤0.01% 405
2021
Q3
$147K Hold
12,218
﹤0.01% 401
2021
Q2
$183K Hold
12,218
﹤0.01% 403
2021
Q1
$202K Buy
+12,218
New +$231K ﹤0.01% 378

Other funds holding MESO

Rathbones Group's MESO Position: Q1 2026 in Review

Rathbones Group held its Mesoblast (MESO) position steady in Q1 2026 at 14,017 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Rathbones Group first reported a position in MESO in Q1 2021 and has held it in 20 quarters since. The position peaked at $278K in Q4 2024. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Rathbones Group held 14,017 shares of Mesoblast worth $216K as of Q1 2026.
  • Rathbones Group left its Mesoblast share count unchanged in Q1 2026.
  • Mesoblast made up ﹤0.01% of Rathbones Group's portfolio in Q1 2026, its #574 holding.
  • Rathbones Group first reported a position in Mesoblast in Q1 2021 and has held it in 20 quarters since.
  • Rathbones Group's Mesoblast position peaked at $278K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.